ArticleCancer gene therapy2010

Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.

M Takakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.